CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use the original agreement and policy sources for this record to identify the exact clause, its legal source, and the stated consequence. Preserve those facts before reaching a conclusion about a particular provider or condition.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
Alaska · Contract for Care
Alaska Pain Specialists — Pain Management Agreement — Contract for Care Review
Public agreement
Current forms page links a packet named Updated-new-patient-packet-9.24.26.pdf. Agreement appears on PDF pages 13–14. Actual signed use and applicability at each branch remain unconfirmed.
Read the source document · Practice/source context
The table paraphrases selected conditions; read the complete source for exceptions and surrounding language. Compare each term with the Alaska regulatory and incorporated-guidance baseline. Classifications are research judgments, not legal determinations.
| Condition | Source provision / location | Classification | Comparison and question to resolve |
|---|---|---|---|
| 90-MME ceiling | A1, p.13: taper patients above 90 MME to 90 or less; no new prescriptions above 90. | Office-specific threshold implementation | CDC 2016 recommendation 5 permits carefully justified decisions at or above 90; Alaska’s separate 50-MME rule addresses specified initial prescriptions. Neither is a universal ongoing 90-MME ceiling. |
| Law-enforcement waiver | G, p.13: cooperation with law enforcement and waiver of privilege, privacy and confidentiality. | No matching blanket waiver located | Assessment and lawful disclosure duties do not themselves establish a compulsory, unlimited waiver. Ask which authority requires this wording and what refusal changes. |
| Mental-health disclosures | D, p.13: unrestricted information exchange with mental-health practitioners. | Office-specific disclosure scope | Care coordination is a recognized objective; necessity, recipients, scope, revocation and separate consent require their own review. |
| Testing and payment | E, p.13: screening, uncovered costs paid by patient; refusal at specified time may end services. | Mixed: monitoring supported; payment/consequence specified by office | FSMB 2017 supports periodic testing. That does not set this clinic’s charges or automatically establish its stated consequence. |
| Alaska-only pharmacy/travel | A and I, pp.13–14: Alaska-only fills; travel beyond 30 days requires another provider. | Mixed: single pharmacy supported; geographic condition added | FSMB 2017 supports one pharmacy. Its agreement recommendations do not themselves prescribe an Alaska-only travel arrangement. |
| Outside/ER prescriptions | B–C, p.13: outside approval and prior on-call discussion for ER take-home narcotics. | Mixed: coordination supported; emergency workflow added | Single-prescriber expectations have guideline support. Ask for the exact emergency exception and safe handoff process. |
| Alcohol and cannabis | F–G, p.13: alcohol restriction and possible termination for substances including marijuana. | Office implementation of risk management | Guidelines address interactions and risk; the particular prohibition and consequence must be distinguished from those objectives. |
| Lost medication | H, p.13: no replacement for lost, stolen or damaged medicine. | Office-selected replacement rule | FSMB recommends explaining replacement policies; it does not make every office’s chosen replacement rule identical. |
Facility applicability
- Alaska Pain Specialists — Anchorage
- Peninsula Spine & Pain Clinic — Kenai
- Valley Spine and Pain Clinic — Wasilla
Network association alone does not confirm that every location or patient group signs this version.
Evidence limits: A publicly linked document does not confirm current signed use. “Office-selected” identifies specific wording not located in the general physician authorities reviewed; it is not a finding of illegality, enforceability or clinical necessity. Payer, federal/tribal and profession-specific requirements need separate review. Research checked October 13, 2026 UTC / October 12 Central.
Alaska facility directory · State requirements and incorporated guidance · Evidence library · Method and coverage · Alaska Pain Atlas
Our Legal Case presents Seeds of Vice’s broader legal argument. Listing a practice or reviewing its document is not a court finding about that practice.